Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
Public ClinicalTrials.gov record NCT01082640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Phase 2 Study to Evaluate the Effect of Febuxostat Versus Placebo on Renal Function in Gout Subjects With Hyperuricemia and Moderate to Severe Renal Impairment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effect of febuxostat, once daily (QD) or twice daily (BID), on renal function in gout patients with elevated serum urate levels and who have moderate to severe renal impairment.
Study identification
- NCT ID
- NCT01082640
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2010 (Type not available)
- Primary completion
- May 2012 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Sep 25, 2013
2010 – 2012
United States locations
- U.S. sites
- 58
- U.S. states
- 29
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Sierra Vista | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Huntington Park | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Lakewood | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Jose | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Arvada | Colorado | — | — |
| Not listed | Westminster | Colorado | — | — |
| Not listed | Wheat Ridge | Colorado | — | — |
| Not listed | Middlebury | Connecticut | — | — |
| Not listed | Brandon | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pinellas Park | Florida | — | — |
| Not listed | Port Charlotte | Florida | — | — |
| Not listed | Port Orange | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Conyers | Georgia | — | — |
| Not listed | Dunwoody | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Evergreen Park | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Elizabethtown | Kentucky | — | — |
| Not listed | Paducah | Kentucky | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Brooklyn Center | Minnesota | — | — |
| Not listed | Neptune City | New Jersey | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Fairfax | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Williamsburg | Virginia | — | — |
| Not listed | Clarksburg | West Virginia | — | — |
| Not listed | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01082640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01082640 live on ClinicalTrials.gov.